New study tests laser and PRP boost for acne scar treatment

NCT ID NCT07199608

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three approaches for treating atrophic acne scars: subcision alone, subcision plus fractional CO2 laser, and subcision plus platelet-rich plasma (PRP). Forty-two adults with mild to severe scars will receive treatment on different sides of the face to see which combination works best. The goal is to find a more effective way to improve scar appearance and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

subcision, fractional CO2 laser, platelet-rich plasma (PRP)

What this could lead to

If it works, this could point toward a more effective combination treatment for atrophic acne scars, improving appearance and quality of life.

What could go wrong

This is a small, early-stage trial with only 42 participants, so results may not apply to everyone. The improvements may be modest and not last long-term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHIC ACNE SCAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assiut University Hospitals, Dermatology Department

    Asyut, Asyut Governorate, Egypt

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••